Review





Similar Products

mouse monoclonal anti-flii antibodies raised to the lrr domain of the human flii protein  (Santa Cruz Biotechnology)
90
Santa Cruz Biotechnology mouse monoclonal anti-flii antibodies raised to the lrr domain of the human flii protein
Healing can be improved by the application of <t>Flii</t> <t>neutralizing</t> <t>antibodies.</t> (A) shows macroscopic images of day 0 and day 7 excisional WT diabetic wounds treated with IgG isotype control ( n = 10) and Flii neutralizing antibody (FnAb) ( n = 10). Representative pictures of H&E staining of day 7 diabetic wounds treated with IgG and FnAb. (B) Graphical representation of the (a) wound areas and (b) histological wound gapes of the days 0 and 7 IgG control-treated and FnAb-treated WT diabetic wounds where * P ≤ 0.05 ( n = 10).
Mouse Monoclonal Anti Flii Antibodies Raised To The Lrr Domain Of The Human Flii Protein, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mouse monoclonal anti-flii antibodies raised to the lrr domain of the human flii protein/product/Santa Cruz Biotechnology
Average 90 stars, based on 1 article reviews
mouse monoclonal anti-flii antibodies raised to the lrr domain of the human flii protein - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier
flii protein  (Cowin Biosciences)
90
Cowin Biosciences flii protein
Healing can be improved by the application of <t>Flii</t> <t>neutralizing</t> <t>antibodies.</t> (A) shows macroscopic images of day 0 and day 7 excisional WT diabetic wounds treated with IgG isotype control ( n = 10) and Flii neutralizing antibody (FnAb) ( n = 10). Representative pictures of H&E staining of day 7 diabetic wounds treated with IgG and FnAb. (B) Graphical representation of the (a) wound areas and (b) histological wound gapes of the days 0 and 7 IgG control-treated and FnAb-treated WT diabetic wounds where * P ≤ 0.05 ( n = 10).
Flii Protein, supplied by Cowin Biosciences, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/flii protein/product/Cowin Biosciences
Average 90 stars, based on 1 article reviews
flii protein - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier
purified fliy protein  (Cocalico Inc)
90
Cocalico Inc purified fliy protein
Healing can be improved by the application of <t>Flii</t> <t>neutralizing</t> <t>antibodies.</t> (A) shows macroscopic images of day 0 and day 7 excisional WT diabetic wounds treated with IgG isotype control ( n = 10) and Flii neutralizing antibody (FnAb) ( n = 10). Representative pictures of H&E staining of day 7 diabetic wounds treated with IgG and FnAb. (B) Graphical representation of the (a) wound areas and (b) histological wound gapes of the days 0 and 7 IgG control-treated and FnAb-treated WT diabetic wounds where * P ≤ 0.05 ( n = 10).
Purified Fliy Protein, supplied by Cocalico Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/purified fliy protein/product/Cocalico Inc
Average 90 stars, based on 1 article reviews
purified fliy protein - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

Image Search Results


Healing can be improved by the application of Flii neutralizing antibodies. (A) shows macroscopic images of day 0 and day 7 excisional WT diabetic wounds treated with IgG isotype control ( n = 10) and Flii neutralizing antibody (FnAb) ( n = 10). Representative pictures of H&E staining of day 7 diabetic wounds treated with IgG and FnAb. (B) Graphical representation of the (a) wound areas and (b) histological wound gapes of the days 0 and 7 IgG control-treated and FnAb-treated WT diabetic wounds where * P ≤ 0.05 ( n = 10).

Journal: BioMed Research International

Article Title: The Influence of Flightless I on Toll-Like-Receptor-Mediated Inflammation in a Murine Model of Diabetic Wound Healing

doi: 10.1155/2013/389792

Figure Lengend Snippet: Healing can be improved by the application of Flii neutralizing antibodies. (A) shows macroscopic images of day 0 and day 7 excisional WT diabetic wounds treated with IgG isotype control ( n = 10) and Flii neutralizing antibody (FnAb) ( n = 10). Representative pictures of H&E staining of day 7 diabetic wounds treated with IgG and FnAb. (B) Graphical representation of the (a) wound areas and (b) histological wound gapes of the days 0 and 7 IgG control-treated and FnAb-treated WT diabetic wounds where * P ≤ 0.05 ( n = 10).

Article Snippet: Mouse monoclonal anti-Flii antibodies raised to the LRR domain of the human Flii protein and the rabbit anti-human MyD88 antibody were obtained from Santa Cruz Biotechnology (VIC, Australia).

Techniques: Staining

Modulation of Flii by exogenous application of Flii neutralising antibodies (FnAbs) reduces TLR4 expression in diabetic wounds. (A) Representative images of TLR4 and NF- κ B staining of day 7 diabetic wounds treated with IgG and FnAb. (B) Graphical representation of (a) TLR4 and (b) NF- κ B staining of day 7 diabetic wounds treated with IgG and FnAb. * P ≤ 0.05.

Journal: BioMed Research International

Article Title: The Influence of Flightless I on Toll-Like-Receptor-Mediated Inflammation in a Murine Model of Diabetic Wound Healing

doi: 10.1155/2013/389792

Figure Lengend Snippet: Modulation of Flii by exogenous application of Flii neutralising antibodies (FnAbs) reduces TLR4 expression in diabetic wounds. (A) Representative images of TLR4 and NF- κ B staining of day 7 diabetic wounds treated with IgG and FnAb. (B) Graphical representation of (a) TLR4 and (b) NF- κ B staining of day 7 diabetic wounds treated with IgG and FnAb. * P ≤ 0.05.

Article Snippet: Mouse monoclonal anti-Flii antibodies raised to the LRR domain of the human Flii protein and the rabbit anti-human MyD88 antibody were obtained from Santa Cruz Biotechnology (VIC, Australia).

Techniques: Expressing, Staining